NSAID Effects on Clinical and Imaging Breast Biomarkers
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 114 participants.
Also called NCT01761877
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 114 participants
- Sponsor
- Registry
-
NCT01761877
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01761877. Non-randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2019-02-07 (actual). Results posted on 2023-02-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- NSAID Effects on Clinical and Imaging Breast Biomarkers
- Condition
- Inflammation
- Condition
- Cancer
- Condition
- Pain
- Condition
- Hypertension
- Intervention (Drug)
- Sulindac
- Lead sponsor
- Stony Brook University
Record details
- Record id
cardio:ct-nct01761877- Content hash
2359b679acbf4c5bc3344b446ab419b2d7af932db63b2a5d50e0a2b533db21b7